Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

LY6 Gene Family: Potential Tumor Antigens and Prognostic Biomarkers in Endometrial Cancer

News

May 8, 2023
PRESS RELEASE: On May 4, 2023, a new research paper was published in Oncotarget, entitled, “Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.” continue reading »

Systemic AL Amyloidosis: Current Approach and Future Direction

News

May 5, 2023
PRESS RELEASE: On April 26, 2023, a new review paper was published in Oncotarget, entitled, “Systemic AL amyloidosis: current approach and future direction.” continue reading »

Retinol Disruption and the Role of Vitamin A Metabolism in Colon Cancer

News

May 3, 2023
PRESS RELEASE: On April 26, 2023, a new research perspective was published in Oncotarget, entitled, “Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism.” continue reading »

Crossroads: The Role of Biomarkers in the Management of Lumps in the Breast

News

May 2, 2023
PRESS RELEASE: On April 24, 2023, a new research perspective was published in Oncotarget, entitled, “Crossroads: the role of biomarkers in the management of lumps in the breast.” continue reading »

Defining the Complexity of EGFR Endocytosis in Cancer

Oncotarget

April 27, 2023
In a new editorial perspective, researchers delve into the complex mechanisms underlying EGFR endocytosis and its potential as a therapeutic target. continue reading »